From Fred Imbert: Stocks fell on Tuesday, the first trading day of the week, as weak data out of China and lower global growth estimates from the International Monetary Fund renewed fears of the global economy slowing down. The Dow Jones Industrial Average dropped 200 points, led by losses in DowDuPont and...
Read more »

Newest Stories

X22Report Q: Winds Are Changing, Prepare For the Storm! Q Knows What the Deep State Has Planned. So Do Patriots | The Peoples Economy is Declining At Lightening Speed (Videos)

Piedmont Lithium commences 25,000-metre drill program to extend project life

#Palladium Review $PALL

M2 Cobalt and Jervois Mining become one in a friendly merger

The Cost of the Government Shutdown

Average Gasoline Prices for Week Ending 21 January 2019 Down 34 Cents From A Year Ago

Denison Mines is disrupting the Athabasca Basin with unique style of mining

This is what a billion tons looks like!

S&P500 Key Levels

Time to Privatize the TSA?

Red Tape, Regulations, and “ Free Trade”

Supreme Court Will Let Trump Administration Enforce Transgender Troop Ban While Court Battles Continue

US to Formally Seek Extradition of Huawei Executive Meng Wanzhou

Opposition Leader Pushes for Parliament Vote on New Brexit Referendum

Greenland Ice Melting Faster Than Previously Thought: Study

300 DHS Employees to Return to Work Tuesday

Los Angeles Teachers Strike to Go into Second Week

France and Germany Renew Postwar Vows of Friendship

ROBO Global says artificial intelligence, robotics will create ‘wave of new opportunities’ in 2019

2019 Chevrolet Volt Hybrid Redesign, Price and Review

K12 reports 2Q revenue and earnings that beat the estimates of analysts

Links (1/22/19)

An opportunity in EM stocks?

The Market Ticker - Saints Fans: Get Over It

#S&P500 Review $SPX $SPY

ROBO Global says artificial intelligence and robotics will create a ‘wave of new opportunities’ in 2019

Philly Biz Journal ME Poncet is retiring after 31 years

FT hires head of diversity and inclusion

CONMED zips past Wall Street's 4Q estimates thanks to booming sales

Medlab Clinical takes EMA and FDA approval track as cannabis research continues